Search results
Author(s):
Augustus O Grant
Added:
3 years ago
Perception often lacks reality, and for many cardiologists and other physicians, the image and understanding of the nation's premier private organization dedicated to the prevention and treatment of heart disease and stroke is woefully out of date. For many physicians, the mission of the American Heart Association (AHA) is simply research, education, and advocacy, but it is much more than that…
View more
Jeff Healey
Author
Wolfram Doehner
Job title: Cardiologist
Author
Author(s):
Braghadheeswar Thyagarajan
,
Ankur Kalra
,
Alefiyah Rajabali
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic cardiomyopathy (HCM), with a reported prevalence of AF in HCM of about 25 %.1 Patients with AF in HCM tend to be more symptomatic and have an increased stroke risk compared with patients without HCM.2 While the occurrence and treatment of (symptomatic) AF in HCM have been extensively studied, there is little data…
View more
Author(s):
Giovanni Torsello
,
Konstantinos P Donas
Added:
3 years ago
Stroke is a leading cause of death and disability in the developed world.1 More than 750,000 strokes occur in the US annually,1 and one-third of these patients die during the first few months after their strokes. Acute carotid syndrome (ACS) is defined as a set of signs and symptoms linked to neurological deficits (transient ischemic attack [TIA] or ischemic stroke) caused by carotid occlusive…
View more
Tze-Fan Chao
Author
A John Camm
Research Area(s) / Expertise:
Job title: Professor of Clinical Cardiology
Author
Author(s):
Suneet Mittal
,
Jonathan S Steinberg
,
Andrew Choi
Added:
3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The prevalence of AF increases with age;1 one and approximately 2.3 million US adults are currently afflicted with AF, with that number projected to increase to 5.6 million by the year 2050.2
AF typically results in an irregular rhythm with poorly controlled ventricular rate and loss of atrial…
View more
Michael Jenkins
Research Area(s) / Expertise:
Job title: Consultant Vascular Surgeon
Author
Author(s):
Paulus Kirchhof
Added:
7 months ago
ESC 2023 — Prof Paulus Kirchhof (University Heart & Vascular Center Hamburg, DE) discusses the findings of the NOAH-AFNET 6 trial (NCT02618577).
NOAH-AFNET 6 (Atrial Fibrillation Network, Daiichi Sankyo Europe) was an investigator-initiated, prospective, randomised trial aiming to demonstrate that oral anticoagulation using the NOAC edoxaban is superior to current therapy in stroke prevention,…
View more